Enhanced Activity against Multidrug-Resistant Bacteria through Coapplication of an Analogue of Tachyplesin I and an Inhibitor of the QseC/B Signaling Pathway.
Yu R, Wang J, So LY, Harvey PJ, Shi J, Liang J, Dou Q, Li X, Yan X, Huang YH, Xu Q, Kaas Q, Chow HY, Wong KY, Craik DJ, Zhang XH, Jiang T, Wang Y.
Yu R, et al. Among authors: so ly.
J Med Chem. 2020 Apr 9;63(7):3475-3484. doi: 10.1021/acs.jmedchem.9b01563. Epub 2020 Feb 14.
J Med Chem. 2020.
PMID: 32003561